Our News

Published Scientific Articles

p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes

Switching cyclin D-Cdk4 kinase activity on and off

Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity

Concarlo in the News

Life Sciences Review special edition on BioTech Startup 2022

US biotech start-up set to have huge impact on breast cancer treatment landscape

Concarlo: targeting proliferation and resistance in one go

Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer

Webinars & Talks

Stacy Blain and Arthur Klausner on NewYorkBIOs Virtual Breakfast Series

Heroes of Healthcare –  Episode 50: Shutting the Door on Cancer Cells

Beyond Biotech podcast 24: Concarlo Therapeutics

Targeting p27Kip1 to Treat Drug-Resistance Cancer


“The reward for work well done is the opportunity to do more”

—Jonas Salk

RESI’s Innovator’s Pitch Challenge Winner

Princeton University Women’s Showcase

The 50 Most admired companies: CIO Bio

Top 100 entreprenuers: Alumni List

Top Biotech Startup 2022
Awarded by: Life Sciences Review